|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
Q2 FY2021
As of Jun 30, 2021
|
Q1 FY2021
As of Mar 31, 2021
|
Q4 FY2020
As of Dec 31, 2020
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| ASSETS | ||||||||||||
| Current assets | ||||||||||||
| Due from Sponsor | ||||||||||||
| Cash | ||||||||||||
| Prepaid expenses | ||||||||||||
| Total Current Assets | ||||||||||||
| Deferred offering costs | ||||||||||||
| Investments held in Trust Account | ||||||||||||
| TOTAL ASSETS | ||||||||||||
| LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT | ||||||||||||
| Current liabilities | ||||||||||||
| Accrued expenses | ||||||||||||
| Advance from Sponsor | ||||||||||||
| Accrued offering costs | ||||||||||||
| Due to Sponsor | ||||||||||||
| Total Current Liabilities | ||||||||||||
| Warrant liability | ||||||||||||
| Warrant liabilities | ||||||||||||
| Convertible Promissory Note – Related Party | ||||||||||||
| Related Party | ||||||||||||
| Total convertible Promissory Note – Related Party | ||||||||||||
| Warrant liability | ||||||||||||
| Total Liabilities | ||||||||||||
| Class A ordinary shares subject to possible redemption, $0.0001 par value; 2,194,056 and 32,500,000 shares at $10.83 and $10.15 per share redemption value at September 30, 2023 and December 31, 2022, respectively | ||||||||||||
| Shareholders’ Deficit | ||||||||||||
| Ordinary shares | ||||||||||||
| Class B Ordinary Shares | ||||||||||||
| Total ordinary shares | ||||||||||||
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,125,000 and 8,625,000 shares issued and outstanding at March 31, 2021 and December 31, 2020, respectively | ||||||||||||
| Class B ordinary shares, $0.0001 par value; 20,000,000 shares authorized; 8,125,000 shares issued and outstanding at June 30, 2023 and December 31, 2022 | ||||||||||||
| Additional paid-in capital | ||||||||||||
| Accumulated deficit | ||||||||||||
| Shareholders’ Deficit | ||||||||||||
| Class A Ordinary Shares | ||||||||||||
| Class B Ordinary Shares | ||||||||||||
| Total Shareholders’ Deficit | ||||||||||||
| TOTAL LIABILITIES, REDEEMABLE ORDINARY SHARES AND SHAREHOLDERS’ DEFICIT |
Loading...
